OBJECTIVES: In the Netherlands, surgery for lung cancer is traditionally performed in low-volume hospitals. To assess the need for centralization, we examined early outcome measures and compared results between hospitals and with other European countries.
INTRODUCTION
Quality assessment has been introduced in medicine to improve the standards of care, to guide contracting by health insurance agencies and to account for health-care expenses to politicians and the public. For lung cancer surgery, various performance indicators have been proposed [1, 2] and, in several countries, clinical registries were launched to provide information on process and outcome. International societies, such as the Society of Thoracic Surgeons [3] and the European Society of Thoracic Surgeons [4] , founded their own registries to monitor the quality of thoracic surgery.
In the Netherlands, lung cancer surgery used to be performed in almost every hospital but recommendations were made to prohibit surgery in low-volume institutions. As of 2012, a minimum yearly number of 20 anatomical resections is required for hospitals performing lung surgery. For training hospitals, a minimum yearly number of 50 resections is recommended. Lung surgery is traditionally performed by two different surgical specialties. In 11 hospitals, operations are performed by cardiothoracic surgeons, in 2 hospitals by a cooperation of cardiothoracic surgeons and general surgeons, and in the majority of hospitals operations are performed by general surgeons, who received supplementary training in thoracic surgery.
To assess the association between hospital volume and early outcome measures of lung cancer surgery, we queried data from the Netherlands Cancer Registry (NCR) for the period 2005-10. Moreover, we sought to determine the amount of variation between hospitals and to define relevant case-mix factors.
population-based coverage as of 1989 and covers a nation with 16.7 million inhabitants. Newly diagnosed cancer patients are notified to the registry through hospital discharge diagnoses and notes from pathology departments. After notification, trained registration clerks collect data from the clinical records, including gender, age, date of diagnosis, tumour site and morphology. Information on performance status or comorbidity is not available. Initial treatment is recorded including chemotherapy, radiotherapy and type of surgery. For lung cancer surgery, three postoperative complications are documented: intrathoracic empyema, bronchopleural fistula and rethoracotomy (any cause). Other complications are not recorded. Annual follow-up information is obtained from the Centralized Civil Registry, thus providing information on death after hospital discharge.
Patients with non-surgical treatment or sublobar resections (wedge, segmental) were excluded from the study, as were children, patients with metachronous lung tumours, small cell carcinoma, sarcoma, in situ or carcinoid tumours, and those operated in foreign hospitals. Statistical analysis was performed using Stata 13 and the final series comprised 9597 patients. The type of surgery was coded in four categories: lobectomy, bilobectomy and left or right pneumonectomy. For practical purposes, sleeve lobectomies (n = 193; 2%) were combined with the lobectomy category and carinal resections (n = 3) were recoded as pneumonectomy.
Postoperative mortality (POM) was defined as death within 30 days of surgery, including deaths after clinical discharge. POM rates were tabulated and prognostic factors were assessed using multivariable logistic regression. For the comparison of POM rates by hospital, a general case-mix model was developed to adjust for variation in patient characteristics. The case-mix model was also applied to explore a large cluster of potential prognostic factors. These presumed risk factors were evaluated consecutively, ignoring records with missing values.
Hospital volume was calculated as the average annual number of resections performed during the study period and only reflects the years in which lung surgery was performed within the individual hospitals. The number of hospitals performing surgery for lung cancer diminished during the study period from 79 in 2005 to 69 in 2010 as several hospitals either merged or discontinued lung surgery. If Hospital A merged with Hospital B to become Hospital AB, results were assigned to three individual hospitals, depending on the year of surgery. Hospital volume was evaluated both continuously and with cut-off values of 20 and 50 resections. These cut-off values reflect the volume recommendations for the Netherlands. The association between surgical specialty and POM was analysed after stratification by period, to account for existing interaction. Season and weekday were previously suggested as predictive factors [5, 6] and were defined by the date of surgery. Information on the type of thoracotomy, video-assisted thoracoscopic (VATS) versus open, was recorded as of 2010 and the comparisons consequently reflect a 1-year sample only. The pTNM stage was recorded according to the 6th edition for 2005-09 and according to the 7th edition as of 2010. The number of lymph nodes examined was calculated by summarizing the numbers from mediastinal examination (mediastinoscopy, endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS)), mediastinal exploration and the lung specimen.
Owing to the nature of the three complications that were recorded, combined occurrence of complications was common. To simplify the analysis, major surgical morbidity was assigned as a composite variable if any of the three complications was observed. Records were not included in the morbidity evaluation if information on complications was not specifically recorded (8.4%). Major morbidity was tabulated and risk factors were assessed using multivariable logistic regression. Major morbidity rates were stratified by hospital and adjusted for variation in relevant patient characteristics.
Pneumonectomy may be averted by appropriate use of sleeve resections and the pneumonectomy proportion has been submitted as a potential performance indicator. Results can, however, be deceiving in case of selective referral of patients with large tumours. Risk factors for pneumonectomy proportions were tabulated and prognostic factors were assessed using multivariable logistic regression. Pneumonectomy proportion was tabulated by hospital and adjusted for variation in relevant patient characteristics.
For the three main outcome measures, POM rate, major surgical morbidity rate and pneumonectomy proportion, results are projected using so-called funnel graphs [7] . In these graphs, individual hospitals are plotted according to the outcome measure (Y-axis) and hospital volume (X-axis). Statistical 95% control limits (CL) are calculated using a binominal approximation and tend to be very wide for low volumes. The cumulative hospital volume reflects the number of operations during a 6-year period. Cumulative volume may reflect a shorter period if lung cancer surgery was discontinued or when individual hospitals merged. Hospital volume numbers may differ for the funnel graph regarding major morbidity due to exclusion of records without information on complications.
Given the large number of hospitals involved, Type I statistical error may occur due to multiple comparisons.
RESULTS
During the period 2005-10, 9579 patients underwent resection for lung cancer (Table 1 ). The median age of patients was 65 years and 34% were 70 years or older. Women comprised 37% of patients overall, but in the age group younger than 60 years, 53% of patients were female. Lobectomy comprised 77% of all procedures, with bilobectomy comprising 9% and pneumonectomy 14% . The POM rate was 2.7% on average and decreased with time from 3.3% for 2005-07 to 2.1% for 2008-10. The improvement with time (odds ratio (OR) = 0.7) was independent of the other risk factors. The POM increased with age and extent of surgery. Right pneumonectomy generated higher POM rates than left pneumonectomy. The POM was twice as high for men, even after adjusting for other prognostic factors.
Twenty-nine percent of all patients were operated in a low-volume hospital (<20/year) and 22% were operated in a high-volume hospital (≥50/year). POM was not associated with hospital volume, neither as a continuous variable (P = 0.34) nor for the cut-off values of 20 and 50 resections ( Table 2) . Surgical specialty was associated with POM in the first 3 years but, in the second period, POM was similar for cardiothoracic and general surgeons. Analysis of the weekday of operation demonstrated higher mortality for surgery on Fridays (OR = 1.61, 13% of operations) and during weekends (OR = 2.93, 2% of operations). POM was similar for adenocarcinoma and squamous carcinoma but higher for patients with large cell carcinoma (OR = 1.69). Type of approach, VATS versus open, did not affect POM. The POM was high for patients with a diagnosis-treatment interval of more than 6 weeks (4.1%). The POM was higher for pTNM stages III-IV and lower for patients with six or more lymph nodes examined. Previous mediastinoscopy and neoadjuvant treatment had no impact on POM, whereas the POM was higher for patients with residual disease. The POM funnel graph (Fig. 1) gives an impression of variation between hospitals. The control limits revealed six outliers with a POM above expected. For one hospital, the POM rate was beneath the lower control limit. Major morbidity was observed in 8.3% of operations and was associated with a POM of 6.6% and a 90-day mortality of 13.8%. Individual complications comprised rethoracotomy (n = 476, 5.4%), intrathoracic empyema (n = 312, 3.6%) and bronchopleural fistula (n = 136, 1.5%). The main risk factors were type of surgery and gender (Table 3 ). Risk was clearly higher for men and right-sided resections. In contrast with a priori assumptions, age was not associated with the risk of major morbidity (P = 0.17). The major morbidity funnel graph (Fig. 2) demonstrates a broad neutral zone between the control limits. Eight outliers were detected above the upper control limit, two hospitals exactly overlapping, and for four hospitals morbidity rates surpassed the lower control limit. No apparent association between volume and morbidity is observed.
The pneumonectomy proportion decreased from 18% in 2005 to 11% in 2010. The proportion of sleeve resections was 2% and this proportion remained stable over time. Major determinants of the pneumonectomy proportion were gender, age, period, tumour side and morphology (Table 4) . Pneumonectomy was less common for women, adenocarcinoma and patients aged 80 years or older. The pneumonectomy funnel graph (Fig. 3) suggests major variation between hospitals with eight hospitals above the upper control limit and six outliers below the lower control limit. No apparent association between volume and pneumonectomy proportion is observed.
DISCUSSION
The early outcome measures for lung cancer surgery in the Netherlands exhibit a POM rate of 2.7%, which is comparable with figures reported for other European countries ( Table 5 ). The results improved considerably after 2007, suggesting that the European reference figures may be outdated. More than half of the Dutch hospitals performed less than 20 operations per year, whereas only 7 performed more than 50 operations. Countries such as Norway, Belgium and Finland also accommodate surgery in low-volume hospitals, but the POM appears to be similar to outcome data from countries with high-volume hospitals. Worldwide, there is a tendency to regionalize thoracic surgical services and a recent meta-analysis reported a POM odds ratio of 0.71 in favour of highvolume hospitals [17] . That review was dominated by studies from the USA and the overall outcome may not reflect thoracic surgery in Europe. A recent French study evaluated almost 20 000 major lung resections and failed to show an association between POM and hospital volume [16] . The critical question remains as to which institutional resources or procedure thresholds are needed to guarantee adequate lung surgery. Kozower et al. [18] evaluated 40 460 lung cancer resections from the Nationwide Inpatient Sample Database and, despite the large sample, they were unable to define a relevant volume threshold. Aberrant results were observed for hospitals performing less than three resections per year but this may reflect emergency operations. Volume was judged to be a poor proxy measure for quality and supplementary information was demanded to explain institutional variation. Comprehensive clinical databases evolved as a valuable tool to monitor quality of care and several professional societies founded registries to convey information on hospital performance. For low-volume hospitals, however, small numbers may hamper reliable evaluation of results. Postoperative death has become a rare event and procedure numbers tend to be insufficient to detect even a doubling of the mortality rate [19] . Also, just by chance, low-volume hospitals tend to end up in the top or bottom of hospital 'league tables' [7] . We detected only seven outliers for POM, six above and one below the control limits, despite combining information over a 6-year period. The wide control limits of the funnel graph suggest that annual evaluation will mainly produce statistical noise and minimum samples are to be defined for meaningful performance assessment [20] . As of 2012, a minimum number of 20 anatomical resections is required in the Netherlands for hospitals performing lung surgery. This threshold is substandard compared with ESTS/EACTS recommendations [21] but even in the USA, hospital volume numbers are surprisingly low. Despite widespread attention for selective referral to high-volume centres, the median number of lung resections per hospital only showed a marginal increase from 18 for 1999-2000 to 25 for 2007-08 [22] .
Apart from volume, several other prognostic factors demand consideration. Firstly, the increased surgical risk for operations on Fridays was suggested previously [6] and this finding is now corroborated by our results. The underlying mechanism is not yet known and the finding may reflect confounding by urgency. The Friday phenomenon was more pronounced for lung surgery than for other surgical procedures [6] , emphasizing the importance of checking for complications in the first 2 days after lung surgery. Hospitals will need to review whether satisfactory standards of postoperative care are also achieved on Fridays and during weekends. Secondly, the POM was apparently not affected by the surgical approach. VATS surgery is increasingly popular and recent studies claimed shorter hospital stay and reduced complication rates with it. These findings may be subject to selection bias and, for definite conclusions, randomized trials have to be awaited. Thirdly, systematic mediastinal lymph node dissection is recommended by most guidelines but the actual implementation is below expectancy. A recent American study based on surveillance, epidemiology, and end results data [23] reported that, in 62% of patients, mediastinal lymph nodes were not examined. Similar results were described by a study based on information from four Dutch hospitals [24] . The current results suggest that major concern about the morbidity of mediastinal dissection is undue because the POM was actually lower if more lymph nodes were retrieved. However, given the potential influence of unmeasured confounders, this issue needs to be resolved in the setting of a randomized trial. Fourthly, POM was slightly increased for patients with a long delay between diagnosis and surgery. This finding cannot be properly interpreted without corresponding information on performance status or comorbidity. It may simply reflect high-risk patients who require additional diagnostics or preoperative measures before being declared fit for surgery. Lastly, it is reassuring that preoperative chemotherapy did not affect the POM. Previous studies had warned against the high risk of pneumonectomy after induction chemotherapy but these concerns are not confirmed by our series. Apart from 30-day mortality, other performance indicators need to be taken into consideration. Non-fatal complications can have an important impact on quality of life but will not turn up in mortality statistics. Owing to cancer registry regulations, only three complications had been recorded. For monitoring purposes, surgical complications such as empyema and bronchopleural fistula need to be distinguished from general complications like atrial fibrillation and pneumonia. The combined morbidity rate seems rather high (8.3%) but rethoracotomy may be performed for separate reasons, such as prolonged air leak or R1 residual disease. The extensive variation between hospitals may relate to variation in coding practice, except for rethoracotomy, which can be easily assessed. Against expectation, the combined morbidity rate was independent of age. The dominant risk factor was type of surgery and a high risk was observed for operations of right-sided tumours. Bilobectomy even appeared to be more hazardous than left pneumonectomy. Right pneumonectomy is still a major procedure with a substantial risk of surgical complications (22%), 30-day mortality (8.6%) and 90-day mortality (13.1%).
The pneumonectomy proportion has been proposed as a performance indicator to monitor the appropriate use of sleeve resections. Sleeve lobectomy comprised only 2% of all operations, similar to surgery practice in the UK [13] , and this figure may represent a universal ceiling due to anatomical constraints. Internationally, pneumonectomy proportions vary widely, ranging from 6% in the USA [3] to 23% in Spain [15] . In Denmark, pneumonectomy proportions decreased after centralization of surgery from 22% in 2000 to 11% in 2007 [14] , and also in Norway, pneumonectomy proportions were shown to decline [8] . A corresponding reduction in the pneumonectomy proportion in the Netherlands could be considered a marker of progress, but this interpretation is debatable since pneumonectomy may be inevitable in patients with large or centrally located tumours. The substantial variation between hospitals may be related to the fact that some hospitals tend to refer pneumonectomy candidates to specialized centres.
Outcome measures can be combined with process or infrastructure standards to establish criteria for accreditation. For thoracic surgery units participating in the ESTS database project, Brunelli et al. [25] combined information from outcome and process indicators to derive composite performance scores. The question emerges as to how this kind of information should be applied to improve results. Interventions may comprise surgical training, change of processes or infrastructure but may also imply discontinuation of thoracic surgery in a specific hospital. Retrospective audit studies or site visits by peer experts may offer recommendations for further action.
Public disclosure of performance data is frequently demanded but surmises that health authorities, patients and health insurance organizations know how to interpret the results.
This study was primarily meant as a basic inventory of surgery for lung cancer in the Netherlands and has several limitations. Firstly and most importantly, the case-mix models lacked information on performance status or comorbidity. The French [13] and American [3] registry studies incorporated detailed clinical information and were able to develop comprehensive prediction models, which can also be used for decision-making in the preoperative setting. For monitoring purposes, however, simpler models may suffice [20] . Secondly, a large number of changes occurred concomitantly during the study period. For example VATS, EUS and EBUS were introduced and the number of hospitals performing lung cancer surgery decreased from 79 to 69. Thirdly, only three outcome measures were studied and information on the extent of preoperative and intraoperative mediastinal staging, important features of surgical performance, was not included in detail.
In conclusion, POM in the Netherlands was similar to results from other European countries, despite a high proportion of lowvolume hospitals. To improve the surgical outcome for patients with lung cancer, volume thresholds are implemented and the centralization of lung surgery is ongoing. To monitor these developments, a dedicated national lung surgery registry was established in 2012, which includes detailed information on comorbidity and complications. Future registry reports will show which performance indicators can reveal excellence in lung cancer surgery.
